Sanofi Sees Unusually Large Options Volume (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) was the target of some unusual options trading activity on Monday. Stock investors purchased 2,013 put options on the company. This is an increase of 68% compared to the average volume of 1,201 put options.

Sanofi Stock Performance

Shares of SNY opened at $52.97 on Wednesday. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. The stock has a market cap of $134.43 billion, a P/E ratio of 27.03, a P/E/G ratio of 1.19 and a beta of 0.57. The business’s 50 day moving average price is $48.90 and its 200-day moving average price is $52.22. Sanofi has a 52 week low of $45.22 and a 52 week high of $58.97.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th.

Hedge Funds Weigh In On Sanofi

Several institutional investors and hedge funds have recently modified their holdings of the stock. Jennison Associates LLC boosted its position in shares of Sanofi by 938.0% during the third quarter. Jennison Associates LLC now owns 1,904,445 shares of the company’s stock valued at $109,753,000 after buying an additional 1,720,972 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in shares of Sanofi by 28,890.2% in the third quarter. Thrivent Financial for Lutherans now owns 1,429,219 shares of the company’s stock worth $82,366,000 after acquiring an additional 1,424,289 shares during the period. DAVENPORT & Co LLC raised its holdings in shares of Sanofi by 40.7% during the fourth quarter. DAVENPORT & Co LLC now owns 2,295,569 shares of the company’s stock valued at $110,715,000 after purchasing an additional 664,455 shares during the last quarter. JPMorgan Chase & Co. grew its position in Sanofi by 20.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,310,809 shares of the company’s stock worth $133,172,000 after purchasing an additional 399,301 shares during the period. Finally, Franklin Resources Inc. lifted its holdings in shares of Sanofi by 13.1% during the 3rd quarter. Franklin Resources Inc. now owns 3,407,452 shares of the company’s stock valued at $208,106,000 after buying an additional 395,744 shares during the period. 14.04% of the stock is currently owned by institutional investors.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.